Pancreatic islet and stem cell transplantation in diabetes mellitus: Results and perspectives

Advances in Experimental Medicine and Biology

Volumn 534, Issue , 2003, Pages 69-96

  Bretzel, Reinhard G ^a  

^a UNIVERSITY HOSPITAL GIESSEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDIABETIC AGENT;

HUMAN; HYPOGLYCEMIA; IMMUNOSUPPRESSIVE TREATMENT; INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PANCREAS ISLET CELL; PANCREAS TRANSPLANTATION; PRIORITY JOURNAL; REVIEW; STEM CELL TRANSPLANTATION; PANCREAS ISLET TRANSPLANTATION;

DIABETES MELLITUS, TYPE 1; HUMANS; ISLETS OF LANGERHANS TRANSPLANTATION; STEM CELL TRANSPLANTATION;

EID: 1542752546     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-4615-0063-6_6     Document Type: Review

References (118)

1. The Diabetes Control and Complications Trial Research Group, 1993, The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N. Engl. J. Med. 329, 977-986.
2. Wang, P.H., Lau, J., and Chalmers, T.C., 1993, Meta-analysis of effects of intensive blood-glucose control on late complications of type-1 diabetes. Lancet 341, 1306-1309.
3. The Diabetes Control and Complications Trial Research Group, 1997, Hypoglycemia in the Diabetes Control and Complications Trial. Diabetes 46, 271-286
4. Sutherland, D.E., Gores, P.F., Farney, A.C., Wahoff, D.C., Matas, A.J., Dunn, D.L., Gruessner, R.W., and Najarian, J.S., 1993, Evolution of kidney, pancreas, and islet transplantation for patients with diabetes at the University of Minnesota. Am. J. Surg. 166, 456-491.
5. Bretzel, R.G., Browatzki, C.C., Schultz, A., Brandhorst, H., Klitscher, D., Bollen, C.C., Raptis, G., Friemann, S., Ernst, W., Rau, W.S., and Hering, B.J., 1993, Clinical islet transplantation in diabetes mellitus - report of the Islet Transplant Registry and the Giessen Center experience. Diab. Stoffw. 2, 378-390.
6. Gruessner, R.W.G., Sutherland, D.E.R., Troppmann, C., Benedetti, E., Hakim, N., Dunn, D.L., and Gruessner, A.C., 1997, The surgical risk of pancreas transplantation in the cyclosporine era: an overview: J. Am. Coll. Surg. 185, 128-144.
7. Manske, C.L., 1999, Risks and benefits of kidney and pancreas transplantation for diabetic patients. Diabetes Care 22, B114-B120.
8. Humar, A., Kandaswamy, R., Granger, D. et al., 2000, Decreased surgical risks of pancreas transplantation in the modern era. Ann. Surg. 231, 342-344.
9. Weimar, B., Rauber, K., Brendel, M.D., Bretzel, R.G., and Rau, W.S., 1999, Percutaneous transhepatic catheterization of the portal vein: a combined CT- and fluoroscopy-guided technique. Cardiovasc. Intervent. Radiol. 22, 342-344.
10. Scharp, D.W., Lacy, P.E., Santiago, J.V., McCullough, C.S., Weide, L.G., Falqui, L. et al., 1990, Insulin independence after islet transplantation into type I diabetic patient. Diabetes 39, 515-518.
11. Socci, C., Falqui, L., Davalli, A.M., Ricordi, C., Braghi, S., Bertuzzi, F. et al., 1991, Fresh human islet transplantation to replace pancreatic endocrine function in type 1 diabetic patients. Report of six cases. Acta Diabetol. 28, 151-157.
12. Warnock, G.L., Kneteman, N.M., Ryan, E.A., Rabinovitch, A., and Rajotte, R.V., 1992, Long-term follow-up after transplantation of insulin-producing pancreatic islets into patients with Type 1 (insulin-dependent) diabetes mellitus. Diabetologia 35, 89-95.
13. Gores, P.F., Najarian, J.S., Stephanian, E., Lloveras, J.J., Kelley, S.L., and Sutherland, D.E.R., 1993, Insulin independence in type I diabetes after transplantation of unpurified islets from single donor with 15-deoxyspergualin. Lancet 341, 19-21.
14. Alejandro, R., Lehmann, R., Ricordi, C., Kenyon, N.S., Angelico, M.C., Burke, G. et al., 1997, Long-term function (6 years) of islet allografts in type 1 diabetes. Diabetes 46, 1983-1989.
15. Brendel, M.D., Hering, B.J., Schultz, A.O., and Bretzel, R.G., 2001, International Islet Transplant Registry Newsletter No. 9: 1-20.
16. Bretzel, R.G., 1999, Biological alternatives to insulin therapy. Exp. Clin. Endocrinol. Diabetes 107, S39-S43.
17. Mering, J. von, and Minkowski, O., 1890, Diabetes mellitus nach Pankreasexstirpation. Arch. Exp. Pathol. Pharmakol. 26, 37.
18. Minkowski, O., 1892, Weitere Mittheilungen über den Diabetes mellitus nach Exstirpation des Pankreas. Berliner Klin. Wochenschr. 29, 90-94.
19. Banting, F.G., and Best, C.H., 1922, The internal secretion of the pancreas. J. Lab. Clin. Invest. 7, 251-266.
20. Williams, P.W., 1894, Notes on diabetes treated with extract and by grafts of sheep's pancreas. Brit. Med. J. 2, 1303.
21. Ricordi, C., Lacy, P.E., Finke, E.H., Olack, B.J., and Scharp, D.W., 1988, Automated method for isolation of human pancreatic islets. Diabetes 37, 413-420.
22. Johansson, B.L., Borg, K., Fernqvist-Forbes, E., Odergren, T., Remahl, S., and Wahren, J., 1996, C-peptide improves autonomic nerve function in IDDM patients. Diabetologia 39, 687-695.
23. Wahren, J., and Johansson, B.L., 1998, New aspects of C-peptide physiology. Horm. Metab. Res. 30, A2-A5.
24. Steiner, D.F., and Rubenstein, A.H., 1997, Proinsulin C-peptide - biological activity? [comment]. Science 277, 531-532.
25. Ido, Y., Vindigni, A., Chang, K., Stramm, L., Chance, R., Heath, W.F., DiMarchi, R.D., Di Cera, E., and Williamson, J.R., 1997, Prevention of vascular and neural dysfunction in diabetic rats by C-peptide. Science 277, 563-567.
26. Meyer, C., Hering, B.J., Grossmann, R., Brandhorst, H., Brandhorst, D., Gerich, J., Federlin, K., 61nd Bretzel, R.G., 1998, Improved glucose counterregulation and autonomic symptoms after intraportal islet transplants alone in patients with type I diabetes mellitus. Transplantation 66, 233-240.
27. Brandhorst, D., Brandhorst, H., Hering, B.J., Federlin, K., and Bretzel, R.G., 1995, Islet isolation from the pancreas of large mammals and humans: 10 years of experience. Exp. Clin. Endocrinol. Diabetes 103 (suppl 2), 3-14.
28. Hering, B.J., Bretzel, R.G., Hopt, U.T., Brandhorst, H., Brandhorst, D., Bollen, C.C., Raptis, G., Helf, F., Grossmann, R., Mellert, J., Ernst, W., Scheuermann, E.H., Schoeppe, W., Rau, W., and Federlin, K., 1994, New protocol toward prevention of early human islet allograft failure. Transplant. Proc. 26, 570-571.
29. Bretzel, R.G., Brandhorst, D., Brandhorst, H., Eckhard, M., Ernst, W., Friemann, S., Rau, W., Weimar, B., Rauber, K., Hering, B.J., and Brendel, M.D., 1999, Improved survival of intraportal pancreatic islet cell allografts in patients with type 1 diabetes mellitus by refined peritransplant management. J. Mol. Med 77, 140-143.
30. Vargas, F., Vives-Pi, M., Somoza, N., Armengol, P., Alcalde, L., Marti, M., Costa, M., Serradell, L., Dominguez, O., Fernandez-Llamazares, J., Julian, J.F., Samarti, A., and Pujol-Borrell, R., 1998, Endotoxin contamination may be responsible for the unexplained failure of human pancreatic islet transplantation. Transplantation 65, 722-727.
31. Kaufman, D.B., Platt, J.L., Rabe, F.L., Dunn, D.L., Bach, F.H., and Sutherland, D.E.R., 1990, Differential roles of Mac-1+ cells and CD4+ and CD8+ T lymphocytes in primary nonfunction and classical rejection of islet allografts. J. Exp. Med. 172, 291-302.
32. Bottino, R., Fernandez, L.A., Ricordi, C., Lehmann, R., Tsan, M.F., Oliver, R., and Inverardi, L., 1998, Transplantation of allogeneic islets of Langerhans in the rat liver. Effects of macrophage depletion on graft survival and microenvironment activation. Diabetes 47, 316-323.
33. Menger, M.D., Vajkoczy, P., Leiderer, R., Jager, S., and Messmer, K., 1992, Influence of experimental hyperglycemia on microvascular blood perfusion of pancreatic islet isografts. J. Clin. Invest. 90, 1361-1369.
34. Berney, T., Molano, R.D., Cattan, P. et al., 2001, Endotoxin-mediated delayed islet graft function is associated with increased intra-islet cytokine production and islet cell apoptosis. Transplantation 71, 125-132.
35. Bennet, W., Sunberg, B., Groth, C.G. et al., 1999, Incompatibility between human blood and isolated islets of Langerhans: a finding with implications for clinical intraportal islet transplantation? Diabetes 48, 1907-1914.
36. El-Ouaghlidi, A., Jahr, H., Pfeiffer, G., Hering, B.J., Brandhorst, D., Brandhorst, H., Federlin, K., and Bretzel, R.G., 1999, Cytokine mRNA expression in peripheral blood cells of immunosuppressed human islet transplant recipients. J. Mol. Med. 77, 115-117.
37. Shapiro, A.M., Gallant, H., Hao, E., Wong, J., Rajotte, R., Yatscoff, R., and Kneteman, N., 1997, Portal vein immunosuppressant levels and islet graft toxicity. Transplant. Proc. 30, 641.
38. Drachenberg, C.B., Klassen, D.K., Weir, M.R., Wiland, A., Fink, J.C., Bartlett, S.T., Cangro, C.B., Blahut, S., and Papadimitriou, J.C., 1999, Islet cell damage associated with tacrolimus and cyclosporine: morphological features in pancreas allograft biopsies and clinical correlation. Transplantation 68, 396-402.
39. Jaeger, C., Hering, B.J., Dyrberg, T., Federlin, K., and Bretzel, R.G., 1996, Islet cell antibodies and GAD65 antibodies in IDDM patients undergoing kidney and islet after kidney transplantation. Transplantation 62, 424-426.
40. Jaeger, C., Brendel, M.D., Hering, B.J., Eckhard, M., and Bretzel, R.G., 1997, Progressive islet graft failure occurs significantly earlier in autoantibody positive than in autoantibody negative IDDM recipients of intrahepatic islet allografts. Diabetes 46, 1907-1910.
41. Jaeger, C., Brendel, M.D., Eckhard, M., and Bretzel, R.G., 2000, Islet autoantibodies as potential markers for disease recurrence in clinical islet transplantation. Exp. Clin. Endocrinol. Diabetes 108, 328-333.
42. Braghi, S., Bonifacio, E., Secchi, A., di Carlo, V., Pozza, G., and Bosi, E., 2000, Modulation of humoral islet autoimmunity by pancreas allotransplantation influences allograft outcome in patients with type 1 diabetes. Diabetes 49, 218-224.
43. Tyden, G., Reinholt, F.P., Sundkvist, G., and Bolinder, J., 1996, Recurrence of autoimmune diabetes in recipients of cadaveric pancreatic grafts. N. Engl. J. Med. 335, 860-863.
44. Halloran, P.F., Homik, J., Goes, N., Lui, S.L., Urmson, J., Ramassar, V., and Cockfield, S.M., 1997, The "injury response": a concept linking nonspecific injury, acute rejection, and long-term transplant outcomes. Transplant. Proc. 29, 79-81.
45. Roep, B.O., Stobbe, I., Duinkerken, G., van Rood, J.J., Lernmark, A., Keymeulen, B., Pipeleers, D., Claas, F.H.J., and de Vries, R.R.P., 1999, Auto- and alloimmune reactivity to human islet allografts transplanted into type-1 diabetic patients. Diabetes 48, 484-490.
46. Shapiro, A.M., Lakey, J.R., Ryan, E.A., Korbutt, G.S., Toth, E., Warnock, G.L., Kneteman, N.M., and Rajotte, R.V., 2000, Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen. N. Engl. J. Med. 343, 230-238.
47. Ryan, E.A., Lakey, J.R.T., Rajotte, R.V. et al., 2001, Clinical outcomes and insulin secretion after islet transplantation with the Edmonton protocol. Diabetes 50, 710-719.
48. Hering, B.J., and Ricordi, C., 1999, Results, research priorities, and reasons for optimism: Islet transplantation for patients with type 1 diabetes. Graft 2, 12-27.
49. Shapiro, A.M.J., Suarez-Pinzon, W.L., Power, R., and Rabinovitch, A., 2002, Combination therapy with low dose sirolimus and tacrolimus is synergistic in preventing spontaneous and recurrent autoimmune diabetes in non-obese diabetic mice. Diabetologia 45, 224-230.
50. Boehmer, H. von, and Sarukhan, A., 1999, GAD, a single autoantigen for diabetes, [comment]. Science 384, 1135-1137.
51. Yoon, J.W., Yoon, C.S., Lim, H.W., Huang, Q.Q., Kang, Y., Pyun, K.H., Hirasawa, K., Sherwin, R.S., and Jun, H.S., 1999, Control of autoimmune diabetes in NOD mice by GAD expression or suppression in beta cells. Science 284, 1183-1187.
52. Yakimets, W.J., Lakey, J.R.T., Yatscoff, R.W., Katyal, D., Ao, Z., Finegood, D.T., Rajotte, R.V., and Kneteman, N.M., 1993, Prolongation of canine pancreatic islet allograft survival with combined rapamycin and cyclosporine therapy at low doses. Transplantation 56, 1293-1298.
53. Kneteman, N.M., Lakey, J.R., Wagner, T., and Finegood, D., 1996, The metabolic impact of rapamycin (sirolimus) in chronic canine islet graft recipients. Transplantation 61, 1206-1210.
54. Guo, Z., Chong, A.S., Shen, J., Foster, P., Sankary, H.N., McChesney, L., Mital, D., Jensik, S.C., Gebel, H., and Williams, J.W., 1997, In vivo effects of leflunomide on normal pancreatic islet and syngeneic islet graft function. Transplantation 63, 716-721.
55. Guo, Z., Chong, A.S., Shen, J., Foster, P., Sankary, H.N., McChesney, L., Mital, D., Jensik, S.C., and Williams, J. W., 1997, Prolongation of rat islet allograft survival by the immunosuppressive agent leflunomide. Transplantation 63, 711-716.
56. Waldmann, H., 1999, Transplantation tolerance: where do we stand? Nat. Med. 11, 1245-1248.
57. Acholonu, I.N., and Ildstad, S.T., 1999, The role of bone marrow transplantation in tolerance: organ-specific and cellular grafts. Curr. Opin. Organ Transplant. 4, 189-196.
58. Kenyon, N.S., Chatzipetron, M., Masetti, M., Ranuncoli, A., Oliveira, M., Wagner, J.L., Kirk, A.D., Harlan, D.M., Burkly, L.C., and Ricordi, C., 1999, Long-term survival and function of intrahepatic islet allografts in rhesus monkeys treated with humanized anti-CD 154. Proc. Natl. Acad. Sci. USA 96, 8132-8137.
59. Kenyon, N.S., Fernandez, L.A., Lehmann, R., Masetti, M., Ranuncoli, A., Chatzipetron, M., Iaria, G., Han, D., Wagner, J.L., Ruiz, P., Berho, M., Inverardi, L., Alejandro, R., Mintz, D.H., Kirk, A.D., Harlan, D.M., Burkly, L.C., and Ricordi, C., 1999, Long-term survival and function of intrahepatic islet allografts in baboons treated with humanized anti-CD 154: Diabetes 48, 1473-1481.
60. Fändrich, F., Lin, X., Chai, G.X., Schulze, M., Ganten, D., Bader, M., Holle, J., Huang, D.-S., Panvaresch, R., Zavazava, N., and Binas, B., 2002, Preimplantation-stage stem cells induce long-term allogenic graft acceptance without supplementary host conditioning. Nat. Med 8, 171-178.
61. Chong, A.S., Yin, D., and Boussy, I.A., 2002, Transplantation tolerance: of mice and men. Graft 5, 27-33.
62. Kawai, T., Andrews, D., Colvin, R.B., Sachs, D.H., and Cosimi, A.B., 2000, Thromboembolic complications after treatment with monoclonal antibody against CD40 ligand. Nat. Med 6, 114.
63. Kirk, A.D., and Harlan, D.M., 2000, Thromboembolic complications after treatment with monoclonal antibody against CD40 ligand (reply). Nat. Med 6, 114.
64. Zekorn, T., Horcher, A., Siebers, U., Federlin, K., and Bretzel, R.G., 1995, Islet transplantation in immunoseparating membranes for treatment of insulin-dependent diabetes mellitus. Exp. Clin. Endocrinol. Diabetes 103 (suppl 2), 136-139.
65. Siebers, U., Horcher, A., Bretzel, R.G., Federlin, K., and Zekorn, T., 1997, Alginate-based microcapsules for immunoprotected islet transplantation. In: Bioartificial Organs: Science, Medicine and Technology (A. Prokop, D. Hunkeler, A.D. Cherrington, eds.), Annals of the New York Academy of Sciences Vol. 831, pp. 304-312.
66. Siebers, U., Horcher, A., Brandhorst, H., Brandhorst, D., Hering, B., Federlin, K., Bretzel, R.G., and Zekorn, T., 1999, Analysis of the cellular reaction towards microencapsulated xenogeneic islets after intraperitoneal transplantation. J. Mol. Med. 77, 215-218.
67. de Vos, P., Hamel, A.F., and Tatarkiewicz, K., 2002, Considerations for successful transplantation of encapsulated pancreatic islets. Diabetologia 45, 159-173.
68. Sun, Y., Ma, X., Zhou, D., Vacek, I., and Sun, A.M., 1996, Normalization of diabetes in spontaneously diabetic cynomolgus monkeys by xenografts of microencapsulated porcine islets without immunosuppression. J. Clin. Invest. 98, 1417-1422.
69. Soon-Shiong, P., Heintz, R.E., Merideth, N., Yao, Q.X., Yao, Z., Zheng, T., Murphy, M., Moloney, M.K., Schmehl, M., Harris, M., et al., 1994, Insulin independence in a type 1 diabetic patient after encapsulated islet transplantation. Lancet 343, 950-951.
70. Zekorn, T.D., Horcher, A., Siebers, U., Federlin, K., and Bretzel, R.G., 1999, Synergistic effect of microencapsulation and immunoalteration on islet allograft survival in bioartificial pancreas. J. Mol. Med. 77, 193-198.
71. Evans, R.W., 2001, In: Xenotransplantation (J.L. Platt, ed.), ASM Press, Washington, pp. 29-51.
72. Good, A.H., Cooper, D.K.C., and Malcolm, A.J. et al., 1992, Identification of carbohydrate structures which bind human anti-porcine antibodies: implications for discordant xenografting in man. Transplant. Proc. 24, 559-562.
73. Miyagawa, S., Murakami, H., Takahagi, Y., Nakai, R., Yamada, M., Murase, A., Koyota, S., Koma, M., Matsunami, K., Fukuta, D., Fujimura, T., Shigehisa, T., Okabe, M., Nagashima, H., Shirakura, R., and Taniguchi, N., 2001, Remodeling of the major pig xenoantigen by N-acetylglucosaminyltransferase III in transgenic pig. J. Biol. Chem. 27, 39310-39319.
74. Wennberg, L., Wallgren, A.C., Sundberg, B., Rafael, E., Zhu, S., Tibell, A., Karlsson-Parra, A., Groth, C.G., Korsgren, O., 1995, Efficacy of immunosuppressive drugs in islet Xenotransplantation: a study in the pig-to-rat model. Xenotransplantation 2, 222-229.
75. Wennberg, L., Karlsson-Parra, A., Sundberg, B., Rafael, E., Liu, J., Zhu, S., Groth, C.G., and Korsgren, O., 1997, Efficacy of immunosuppressive drugs in islet Xenotransplantation. Transplantation 63, 1234-1242.
76. Friedman, T., Smith, R.N., Colvin, R.B., and Iacomini, J., 1999, A critical role for human CD4+ T-cells in rejection of porcine islet cell xenografts. Diabetes 48, 2340.
77. Jahr, H., Brandhorst, D., Brandhorst, H., Brendel, M., Eckhardt, T., El-Ouaghlidi, A., Hussmann, B., Lau, D., Nahidi, F., Wacker, T., Zwolinski, A., and Bretzel, R.G., 1998, Abstossungsreaktionen bei der tierexperimentellen xenogenen Transplantation von isolierten Langerhansschen Inseln des Schweins. Zentralbl. Chir. 123, 823-829.
78. Lau, D., Hering, B.J., El-Ouaghlidi, A., Jahr, H., Brandhorst, H., Brandhorst, D., Vietzke, R., Federlin, K., and Bretzel, R.G., 1999, Isokinetic gradient centrifugation prolongs survival of pig islets xenografted into mice. J. Mol. Med. 77, 175-177.
79. Lai, L., Kolber-Simonds, D., Kwang-Wook, P., Cheong, H.-T., Greenstein, J.L., Im, G.-S., Samuel, M., Bonk, A., Rieke, A., Day, B.N., Murphy, C.N., Carter, D.B., Hawley, R.J., and Prather, R.S., 2002, Production of Δ-1,3-galactosyltransferase knockout pigs by nuclear transfer cloning. Science 295, 1089-1092.
80. Brown, J., Danilovs, J.A., Clark, W.R., and Mullen, Y.S., 1984, Fetal pancreas as a donor organ. World J. Surg. 8, 152-157.
81. Korsgren, O., 1991, Xenotransplantation of fetal porcine islet-like cell clusters in diabetes mellitus: an experimental and clinical study. Acta Univ. Upsal. 295, 1-40.
82. Korsgren, O., Sandler, S., Landström, A., Jansson, L., Andersson, A., 1988, Large-scale production of fetal porcine pancreatic islet-like cell clusters. An experimental tool for studies of islet cell differentiation and Xenotransplantation. Transplantation 45, 509-514.
83. Korsgren, O., Jansson, L., Eizirik, D., and Andersson, A., 1991, Functional and morphological differentiation of fetal porcine islet-like cell clusters after transplantation into nude mice. Diabetologia 34, 379-386.
84. Liu, X., Federlin, K.F., Bretzel, R.G., Hering, B.J., and Brendel, M.D., 1991, Persistent reversal of diabetes by transplantation of fetal pig proislets into nude mice. Diabetes 40, 858-866.
85. Liu, X., Brendel, M.D., Hering, B.J., Bretzel, R.G., and Federlin, K., 1992, Comparison of the potency of fetal pig pancreatic proislets and fragments to reverse diabetes. Transplant. Proc. 24, 987.
86. Liu, X., Brendel, M.D., Brandhorst, H., Klitscher, D., Hering, B.J., Federlin, K.F., and Bretzel, R.G., 1993, Successful cryopreservation of fetal porcine proislets. Cryobiology 30, 262-271.
87. Liu, X., Brendel, M.D., Brandhorst, D., Brandhorst, H., Hering, B.J., Federlin, K., and Bretzel, R.G., 1994, Reversal of diabetes in nude mice by transplantation of cryopreserved fetal porcine proislets. Transplant. Proc. 26, 707-708.
88. Bretzel, R.G., Liu, X., Hering, B.J., Brendel, M., and Federlin, K., 1995, Cryopreservation transplantation and susceptibility to diabetogenic agents of fetal porcine proislets. Xenotransplantation 2, 133-138.
89. Soderlund, J., Wennberg, L., Castanos-Velez, E. et al., 1999, Fetal porcine islet-like cell clusters transplanted to cynomolgus monkeys: an immunohistochemical study. Transplantation 67, 784.
90. Groth, C.G., Andersson, A., Björken, C., Gunnarsson, R., Hellerström, C., Lundgren, G., Petersson, B., Swenne, I., and Östman, J., 1980, Transplantation of fetal pancreatic microfragments via the portal vein to a diabetic patients. Diabetes 29, 80-83.
91. Groth, C.G., Korsgren, O., Tibell, A. et al., 1994, Transplantation of porcine fetal pancreas to diabetic patients. Lancet 344, 1402-1404.
92. Bach, F.H., Fishman, J.A., Daniels, N. et al., 1988, Uncertainty in Xenotransplantation: individual benefit versus collective risk. Nat. Med. 4, 141-144.
93. Patience, C., Takeuchi, Y., and Weiss, R.A., 1997, Infection of human cells by an endogenous retrovirus of pigs. Nat. Med. 3, 275-276.
94. Martin, U., Kiessig, V., Blusch, J.H., Haverich, A., von der Helm, K., Herden, T., and Steinhoff, G., 1998, Expression of pig endogenous retrovirus by primary porcine endothelial cells and infection of human cells. Lancet 352, 666-667.
95. Van der Laan, L.J., Lockey, C., Griffeth, B.C. et al., 2000, Infection by porcine endogenous retroviruses after islet Xenotransplantation in SCID mice. Nature 407, 90-94.
96. Deng, Y.M., Tuch, B.E., and Rawlinson, W.D., 2000, Transmission of porcine endogenous retroviruses in severe combined immunodeficient mice xenotransplanted with fetal porcine pancreatic cells. Transplantation 70, 1010-1016.
97. Heneine, W., Tibell, A., Switzer, W.M. et al., 1998, No evidence of infection with porcine endogenous retrovirus in recipients of porcine islet-cell xenografts. Lancet 352, 695-699.
98. Paradis, K., Langford, G., Long, Z. et al., 1999, Search for cross-species transmission of porcine endogenous retrovirus in patients treated with living pig tissue. Science 285, 1236-1241.
99. Soria, B., Skoudy, A., and Martin, F., 2001, From stem cells to beta cells: new strategies in cell therapy of diabetes mellitus. Diabetologia 44, 407-415.
100. Edlund, H., 1958, Transcribing the pancreas. Diabetes 47, 1817-1823.
101. Stoffers, D.A., Zinkin, N.T., Stanojevic, V., Clarke, W.L., and Habener, J.F., 1997, Pancreatic agenesis attributable to a single nucleotide deletion in the human IPF1 gene coding sequence. Nat. Genet. 15, 106-110.
102. Apelqvist, A., Li, H., Sommer, L., Beatus, P., Anderson, D.J., Honjo, T., de Angelis, M., Lendahl, U., and Edlund, H., 1999, Notch signalling controls pancreatic cell differentiation. Nature 400, 877-881.
103. Gradwohl, G., Dierich, A., Le Meur, M., and Guillemot, F., 2000, Neurogenin 3 is required for the development of the four endocrine cell lineages of the pancreas. Proc. Natl. Acad. Sci. USA 97, 1607-1611.
104. Sosa-Pineda, B., Chowdhury, K., Torres, M., Oliver, G., and Gruss, P., 1997, The Pax 4 gene is essential for differentiation of insulin-producing beta cells in the mammalian pancreas. Nature 386, 399-402.
105. Soria, B., Roche, E., Berna, G., Leon-Quinto, T., Reig, J.A., and Martin, F., 2000, Insulin-secreting cells derived from embryonic stem cells normalize glycemia in streptozotocin-induced diabetic mice. Diabetes 49, 157-162.
106. Lumelsky, N., Blondel, O., Laeng, P., Velasco, I., Ravin, R., and McKay, R., 2001, Differentiation of embryonic stem cells to insulin-secreting structures similar to pancreatic islets. Science 292, 1389-1394.
107. Assady, S., Maor, G., Amit, M., Itskovitz-Eldor, J., Skorecki, K.L., and Tzuckerman, M., 2001, Insulin production by human embryonic stem cells. Diabetes 50, 1691-1697.
108. Zulewski, H., Abraham, E.J., Gerlach, M.J., Daniel, P.B., Moritz, W., Muller, B., Vallejo, M., Thomas, M.K., and Habener, J.F., 2001, Multipotential nestin-positive stem cells isolated from adult pancreatic islets differentiate ex vivo into pancreatic endocrine, exocrine, and hepatic phenotypes. Diabetes 50, 521-533.
109. Ramiya, V.K., Maraist, M., Arfors, K.E., Schatz, D.A., Peck, A.B., and Cornelius, J.G., 2000, Reversal of insulin-dependent diabetes using islets generated in vitro from pancreatic stem cells. Nat. Med. 6, 278-282.
110. Bonner-Weir, S., Taneja, M., Weir, G.C., Tatarkiewicz, K., Song, K.H., Sharma, A., and O'Neill, J.J., 2000, In vitro cultivation of human islets from expanded ductal tissue. Proc. Natl. Acad. Sci. USA 97, 7999-8004.
111. Soria, B., Andreu, E., Berna, G., Fuentes, E., Gil, A., Leon-Quinto, T., Martin, F., Montanya, E., Nadal, A., Reig, J.A., Ripoll, C., Roche, E., Sanchez-Andres, and J.V., Segura, J., 2000, Engineering pancreatic islets. Eur. J. Physiol. 440, 1-18.
112. Cheung, A.T., Dayanandan, B., Lewis, J.T., Korbutt, G.S., Rajotte, R.V., Bryer-Ash, M., Boylan, M.O., Wolfe, M.M., and Kieffer, T.J., 2000, Glucose-dependent insulin release from genetically engineered K cells. Science 290, 1959-1962.
113. Lee, H.C., Kim, S.J., Kim, K.S., Shin, H.C., and Yoon, J.W., 2000, Remission in models of type 1 diabetes by gene therapy using a single-chain insulin analogue. Nature 408, 483-488.
114. Shaw, J.A.M., Delday, M.I., Hart, A.W., and Docherty, K., 2002, Secretion of bioactive human insulin following plasmid-mediated gene transfer to non-neuroendocrine cell lines, primary cultures and rat skeletal muscle in vivo. J. Endocrinol. 172, 653-672.
115. Riu, E., Mas, A., Ferre, T., Pujol, A., Gros, L., Otaegui, P., Montoliu, L., and Bosch, F., 2002, Counteraction of type 1 diabetic alterations by engineering skeletal muscle to produce insulin: insights from transgenic mice. Diabetes 51, 704-711.
116. Ferber, S., Halkin, A., Cohen, H., Ber, I., Einav, Y., Goldberg, I., Barshack, I., Seijfers, R., Kopolovic, J., Kaiser, N., and Karasik, A., 2000, Pancreatic and duodenal homeobox gene 1 induces expression of insulin genes in liver and ameliorates streptozotocin-induced hyperglycemia. Nat. Med 6, 568-572.
117. Kahn, A., 2000, Converting hepatocytes to E-cells - a new approach for diabetes? Nat. Med. 6, 505-506.
118. Weir, G.C., and Bonner-Weir, S., 1997, Scientific and political impediment to successful islet transplantation. Diabetes 46, 1247-1256.